mouse model of Streptococcus pyogenes peritonitis. PUM inhibits RNAP through a binding site on RNAP (the "i+1" NTP binding site) and mechanism (competition with UTP for occupancy of the "i+1" NTP binding site) that differ from those of the RNAP inhibitor and current antibacterial drug rifampin (Rif). PUM exhibits additive antibacterial activity when co-administered with Rif, exhibits no cross-resistance with Rif, and exhibits a spontaneous resistance rate an order-ofmagnitude lower than that of Rif. The results provide the first example of a selective NAI of bacterial RNAP, provide an advanced lead compound for antibacterial drug development, and provide structural information and synthetic routes that enable lead optimization for antibacterial drug development.
that PUM functions as an NAI that competes with UTP at positions that direct incorporation of U preceded by positions that direct incorporation of G, A, or U.
To define the structural basis of transcription inhibition by PUM, we determined a crystal structure of a transcription initiation complex containing PUM (RPo-GpA-PUM; Fig. 4a ) and, for comparison, a crystal structure of a corresponding transcription initiation complex containing CMPcPP (RPo-GpA-CMPcPP; Fig. 4b ). The results establish that PUM is an NAI that competes for occupancy of the i+1 site ( Fig. 4) . PUM binds to the i+1 site (Fig. 4a ). The PUM base makes Watson-Crick H-bonds with a DNA template-strand A in a manner equivalent to an NTP base; the PUM sugar moiety makes interactions with the i+1 site in a manner nearly equivalent to an NTP sugar; the PUM glutamine moiety makes interactions that mimic interactions made by an NTP triphosphate; and the PUM N-hydroxy and guanidinyl moieties interact with the RNA nucleotide base-paired to the preceding template position (RNA 3'-nucleotide), with the N-hydroxy donating an H-bond to the 3'-OH of the RNA 3'-nucleotide, and the guanidinyl moiety donating one H-bond to the 5'-phosphate of the RNA 3'-nucleotide and another to the base of the RNA 3'-nucleotide (Fig. 4a ).
The structure of the PUM-inhibited complex accounts for the observed specificity of inhibition for template positions that direct incorporation of U preceded by template positions that direct incorporation of G, A, or U. The Watson-Crick base pair by the PUM base moiety provides absolute specificity for a position directing incorporation of U (Fig. 4a ). The H-bond donated by the PUM guanidinyl moiety with the base of the RNA 3'-nucleotide confers specificity for a preceding position directing incorporation of G, A, or U (each of which contains an H-bond acceptor at the appropriate position; Fig. 4a ).
The structure also explains the selectivity of transcription inhibition by PUM. All RNAP residues contacted by PUM are highly conserved across Gram-positive and Gram-negative bacterial RNAP (Extended Data Fig. 6 ), accounting for the inhibition of both Gram-positive and Gram-negative bacterial RNAP. In contrast, four RNAP residues important for PUM are not conserved in human RNAP I, II, and III (β residues 677, 681, and 684, and β′ residue 932; Extended Data Fig. 6 ), accounting for selectivity for bacterial RNAP over human RNAP I, II, and III.
The structure also explains the small size of the PUM resistance spectrum (four residues in S. pyogenes RNAP; two residues in E. coli RNAP; Fig. 2b ; Extended Data Fig. 4a-b ). PUM makes direct contacts with RNAP residues at which PUM-resistant substitutions are obtained (Extended Data Fig. 6 ).
However, PUM also makes direct contacts with ten other RNAP residues that comprise functionally critical residues of the RNAP active center that cannot be substituted without compromising RNAP activity 5;19- 23 , and thus which cannot be substituted to yield viable resistant mutants 5 (Fig. 4a ). We infer that PUM interacts with a "privileged target" for which most residues (10-12 of 14 residues) have functional constraints that limit substitution to yield viable resistant mutants. Similar results have been reported for the RNAP inhibitor GE, a non-nucleoside-analog inhibitor that binds to the RNAP i and i+1 sites 5 and that exhibits a small target-based resistance spectrum 5 (but that, unlike PUM, exhibits high nontarget-based resistance, presumably at the level of uptake or efflux, precluding development as an antibacterial drug).
The structure enables structure-based design of novel PUM analogs with increased potency and increased selectivity. Initial lead-optimization efforts corroborate the importance of the PUM N-hydroxy, glutamine, and guanidinyl moieties and demonstrate that the PUM glutamine C(O)NH 2 can be replaced by C(O)NHR while retaining RNAP inhibitory and antibacterial activity (Extended Data Fig. 7) .
Our results provide a new class of antibiotic with activity against Gram-positive and Gram-negative bacteria in vitro and in vivo, no cross-resistance with current antibacterial drugs, and low rates of resistance emergence. Our discovery of a new class of antibiotic from conventional microbial extract screening indicates that, contrary to widespread belief 1 , conventional microbial extract screening has not been exhausted as a source of new antibacterial lead compounds.
Our results provide the first example of a selective NAI of bacterial RNAP. NAIs of viral nucleotide polymerases have been of immense importance for development of anti-HIV 3 and anti-HCV 4 drugs. NAIs of bacterial RNAP may show comparable promise for development of antibacterial drugs.
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Data Availability
Atomic coordinates and structure factors for reported crystal structures have been deposited with the Protein Data Bank under accession codes 5X21 (RPo-GpA-PUM) and 5X22 (RPo-GpA-CMPcPP). 
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E. coli RNAP core enzyme
For experiments in Fig. 3c , E. coli RNAP core enzyme was prepared from E. coli strain BL21(DE3) (Invitrogen) transformed with plasmids pEcABC-H6 24 and pCDFω 25 , using procedures as described 26 For experiments assessing promoter-independent transcription in Extended Data Table 1 , E. coli RNAP core enzyme was prepared from E. coli strain XE54 27 transformed with plasmid pRL706 28 , using procedures as described 29 .
E. coli RNAP σ 70 holoenzyme
For experiments in Fig. 3d , E. coli RNAP σ 70 holoenzyme was prepared from E. coli strain XE54 26 transformed with plasmid pREII-NHα 29 , using procedures as described 18 .
For experiments in Extended Data Fig. 4c , E. coli RNAP σ 70 holoenzyme and [565Glu→Asp]β-RNAP σ 70 holoenzyme were prepared from E. coli strain XE54 26 transformed with plasmid pRL706 28 or pRL706-565D 5 , using procedures as described 29 .
B. subtilis RNAP σ A holoenzyme
Rif-resistant B. subtilis [469 (513) Gln→Arg]β-RNAP σ A holoenzyme was prepared from B. subtilis strain MH5636-Q469R (spontaneous Rif-resistant mutant of B. subtilis strain MH5636 30 ; selected on LB agar containing 2 μg/ml Rif; confirmed by PCR amplification and sequencing of rpoB) using procedures essentially as described 30 .
T. thermophilus RNAP σ A holoenzyme
T. thermophilus RNAP σ A holoenzyme was prepared as described 5 .
Microbial extract screening
A sub-library of ~3,000 microbial extracts (prepared as described 31 ) with growth-inhibitory activity against Staphylococcus aureus ATCC 6538 was screened for the ability to inhibit E. coli RNAP and bacteriophage SP6 RNAP (Promega). Screening was performed using 96-well microplates. Reactions contained (50 µl): 5 µl extract (dissolved in 10% DMSO), 0.2 U E. coli RNAP σ 70 holoenzyme (Sigma-Aldrich) or 0.2 U SP6 RNAP (Promega), 0.2 nM plasmid pUC18 (Clontech; for assays with E. coli RNAP) or 0.2 nM plasmid pGEM-3Z (Promega; for assays with SP6 RNAP), 500 µM ATP, 500 µM GTP, 500 µM CTP, and 2 µM [α 32 P]UTP (0.2 Bq/fmol; PerkinElmer), in 20 mM Tris-acetate (pH 7.9), 50 mM KCl, 4 mM magnesium acetate, 0.1 mM EDTA, 5 mM dithiothreitol, and 100 µg/ml bovine serum albumin. Reaction components except DNA were pre-equilibrated 10 min at 22°C. Reactions were initiated by addition of DNA, were allowed to proceed 1 h at 22°C, and were terminated by addition of 150 µl ice-cold 10% (w/v) trichloroacetic acid (TCA). After 1 h at 4°C, resulting TCA precipitates were collected on glass-fiber filters (UniFilter GF/B; PerkinElmer) using a 96-well harvester (Packard) and were washed once with water. Radioactivity was quantified using a TopCount scintillation counter (Packard), and % inhibition was calculated as:
where R sample , R pos and R neg are observed radioactivity levels in a reaction, in a control reaction without extract, and in a control reaction without plasmid, respectively.
Two extracts that inhibited the reaction with E. coli RNAP by ≥80%, that did not inhibit the reaction with SP6 RNAP, and that did not contain mass-spectrometry signals indicative of a previously characterized RNAP inhibitor, were designated as "hit extracts."
Characterization of producer strains
The producer strains of the hit extracts were strains IDI38640 and IDI38673. ID38640 and ID38673 are Actinobacterial isolates from soil samples collected in Italy and France, respectively. ID38640 and ID38673 exhibit cell morphologies consistent with the genus Streptomyces and exhibit 16S rRNA gene sequences (determined as described 32 ; GenBank accession numbers JQ929050 and JQ929051) that were 99.9% identical over 1.4 kB to each other and were highly similar to those of a cluster of closely-related Streptomyces species (S. nigrescens, S. tubercidicus, S. rimosus subsp. rimosus, S. hygroscopicus subsp. angustmyceticus, and S. libani subsp. libani).
Isolation and purification of PUM
For each producer strain of a hit extract, the strain was cultured on a 55 mm BTT agar plate 31 4-7 days at 30°C, the mycelium was scraped from the plate and used to inoculate a 50 ml Erlenmeyer flask containing 15 ml of seed medium (20 g/L dextrose monohydrate, 2 g/L yeast extract, 8 g/L soybean meal, 1 g/L NaCl, and 4 g/L CaCO 3 , pH 7.3), and the resulting culture was incubated 48 h at 30°C on a rotary shaker (200 rpm agitation) for 48 h. Following initial incubation, 5 ml of the culture was used to inoculate 100 ml of fresh seed medium in a 500-ml flask, and the resulting culture was incubated 72 h under the same conditions. A 5% (v/v) inoculum was transferred into 2 L of production medium (10 g/L dextrose monohydrate, 24 g/L maize dextrin, 8 g/L soy peptone, 5 g/L yeast extract, and 1 g/L NaCl, pH 7.2) in a 3-L vessel, and the resulting culture was grown in a BioFlo 115 Fermentor (Eppendorf) 96 h at 30°C, with aeration at 0.5 volume air per volume medium per min stirring at 600 rpm. The culture was filtered through 10.25 in disc filter paper (Scienceware), and the resulting cleared broth was concentrated to ~1 L in vacuo and loaded onto a column of 500 mg of Dowex 50W x 400 mesh (previously activated with two bed volumes of 5% HCl and washed with H 2 O until neutralization). After washing with 5 bed volumes each of 20 mM sodium acetate at pH 6 and sodium acetate at pH 7, PUM was eluted using six bed volumes of 100 mM NH 4 OAc at pH 9. PUM-containing fractions were desalted by reversed-phase medium-pressure liquid chromatography on Combiflash Rf (Teledyne Isco) using a 30 g C18 RediSep Rf column (Teledyne Isco) with linear gradient from 0 to 20% phase B in 20 min (phase A, 0.02% trifluoroacetic acid in H 2 O; phase B, acetonitrile) and flow rate of 35 ml/min. PUM-containing fractions were pooled, concentrated, and lyophilized twice to yield 196 mg of a white solid highly soluble in water, DMSO, and methanol.
Structure elucidation of PUM
Ion-trap ESI-MS (Bruker Esquire 3000 Plus showed a protonated molecular ion at m/z 487 [M+H] + and a bimolecular ion at 973 [2M+H] + Extended Data Fig. 1 ). Ion-trap ESI--MS/MS (Bruker Esquire 3000 Plus ) showed major peaks at m/z 334, 353, 371, 389, 452, and 479 [M+H] + . HR-MS (Thermo Fisher Exactive) showed an exact mass of 487.18865, consistent with the molecular formula C 17 H 26 
Reversed-phase HPLC (Shimadzu Series 10 with SPD-M10A VP diode array detector; Waters Symmetry Shield RP8 5μm, 250 x 4.6 mm, column; phase A = 2 mM heptafluorobutyric acid in water; phase B = 2 mM heptafluorobutyric acid in acetonitrile; gradient = 0% B at 0 min, 10% B at 20 min, 95% B at 30 min; flow rate = 1 ml/min) showed a single peak with a retention time of 12 minutes. The UV-absorbance spectrum showed maxima at 200 nm and 262 nm, consistent with the presence of a pyrimidine moiety 33 (Extended Data Fig. 1 ).
The 1 H NMR spectrum (600 MHz Bruker spectrometer in DMSO-d6 at 25°C) revealed one olefinic (H6), five amide (H6', H3, H5, Hα, and Hε-Gln), four methylene (Hβ-Gln, Hγ-Gln, Hα-Gly, and H5'), and five methine (H1', H2', H3', H4', and Hα-Gln) signals (Extended Data Fig. 2a ). The 2D 1 H-13 C-HSQC and -HMBC NMR spectra (600 MHz Bruker spectrometer in DMSO-d6 at 25°C) identified five carboxyl-amide groups (C2, C4, C=O Gln, C=O Gly, and Cδ-Gln), two olefinic carbons (C1 and C6), four methine carbons belonging to a sugar ring (C1', C2', C3', and C4'), one other methine carbon (Cα-Gln), and four methylene groups (Cα-Gly, Cβ-Gln, Cγ-Gln, and C5') (Extended Data Fig. 2b-c) .
The COSY NMR spectrum (600 MHz Bruker spectrometer in DMSO-d6 at 25°C) identified correlations between the five sugar protons: H1' (δH 4.35), H2' (δH 3.92), H3' (δH 3.65), H4' (δH 3.65) and H5' (δH-A 3.24; H-B 3.17). The chemical shift of C5' and ribose 15 N-HSQC correlations between H6' and H5' indicated the presence of 6'-amino-ribose. Nitrogen signals N2 and N3 in the 15 N HSQC spectrum, HMBC correlations of H1' to C1, C2 and C6, and HMBC correlations of H6 to C1', C1, C2, and C6, indicated the presence of uracil C-linked to C1' of 6'-amino-ribose. 13 C-NMR spectra and COSY indicated the presence of a glutaminyl moiety, and HMBC correlations of H6' and the methine at δ H 4.72 (Hα-Gln) to the carbonyl at δ c 169.5 indicated linkage of the glutaminyl moiety to N6' of 6'-amino-ribose. Nε at δ 108.9 was assigned by 15 N HSQC. The absence of a glutaminyl Nα signal in the 15 N HSQC spectrum suggested the possible presence of an hydroxamic acid, and this was confirmed by reduction of PUM with aqueous TiCl 3 34 to yield desoxy-PUM (1 in Extended Data Fig. 7a The stereochemistry of the glutamine residue was established to be (L) by total hydrolysis followed by chiral GC-MS (Hewlett-Packard HP5985B GC-MS; procedures as described 35 ). The stereochemistry of the ribose sugar was inferred to be D by analogy to the natural product pseudouridine and was confirmed to be D by comparison of desoxy-PUM prepared by reduction of PUM with TiCl 3 to desoxy-PUM prepared by total synthesis using a D-ribose precursor (Extended Data Fig. 7a-b ).
Effects of PUM on macromolecular synthesis
Cultures of Staphylococcus simulans strain M22 in 0.5x Mueller Hinton II broth (BD Biosciences) were incubated at 37°C with shaking until OD 600 = 0.5; diluted in the same medium to OD 600 = 0.1-0.2; supplemented with 6 kBq/ml [2-14 C]-thymidine (Hartmann Analytic), 40 kBq/ml [5-3 H]-uridine (Hartman Analytic), or 6 kBq/ml L-[ 14 C(U)]-isoleucine (Hartman Analytic); and further incubated at 37°C with shaking. After 15 min, cultures were divided into two equal aliquots, PUM was added to one aliquot to a final concentration of 100-200 μM, and cultures were further incubated at 37°C with shaking. At time points 0, 10, 20, and 40 min following addition of PUM, 200 μl aliquots were removed, mixed with 2 ml ice-cold 10% TCA containing 1 M NaCl, and incubated 30-60 min on ice. The resulting TCA precipitates were collected by filtration on glass-microfiber filters (GF/C; Whatman), and filters were washed with 5 ml 2.5% TCA containing 1 M NaCl, transferred to scintillation vials, and dried. Filtersafe scintillation fluid was added (2 ml; Zinnser Analytic), and radioactivity was quantified by scintillation counting (Tri-Carb 3110TR Liquid Scintillation Analyzer; PerkinElmer).
RNAP-inhibitory activity in vitro
For experiments in Fig. 1b and Extended Data Table 1 assessing promoter-dependent transcription by E. coli RNAP, reaction mixtures contained (25 µl): 0-20 µM PUM, 1 U E. coli RNAP σ 70 holoenzyme (Epicentre), 10 nM DNA fragment carrying positions -112 to -1 of E. coli recA promoter 36 followed by transcribed-region positions +1 to +363 of HeLaScribe Positive Control DNA (Promega; sequence at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021065/bin/1471-2199-15-7-S1.docx; yields 363 nt transcript), 20 µM [α 32 P]GTP (0.3 Bq/fmol; PerkinElmer), 400 µM ATP, 400 µM CTP, and 6.25 μM, 50 μM, or 250 μM UTP, in 10 mM Tris-HCl (pH. 7.8), 2 mM HEPES-NaOH, 40 mM KCl, 3 mM MgCl 2 , 0.2 mM dithiothreitol, 0.09 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, and 10% glycerol. Reaction components except RNAP were pre-equilibrated 10 min at 30°C. Reactions were initiated by addition of RNAP, were allowed to proceed 15 min at 30°C, and were terminated by addition of 175 µl HeLa Extract Stop Solution (Promega). Samples were phenol extracted and ethanol precipitated (procedures as described 37 ), and pellets were resuspended in 10 μl 47.5% formamide, 10 mM EDTA, 0.025% bromophenol blue, and 0.01% xylene cyanol and heated 5 min at 95°C. Products were applied to 6% polyacrylamide (19:1 acrylamide:bisacrylamide; 7 M urea) 37 slab gels, and gels were electrophoresed in TBE 37 at 10 V/cm for 1.5 h, dried using a gel dryer (BioRad) 37 , and analyzed by storage-phosphor imaging (Typhoon; GE Healthcare).
For experiments in Fig. 1b and Extended Data Table 1 Table 1 ), in 40 mM Tris-HCl (pH 7.9), 6 mM MgCl 2 , 2 mM spermidine, 10 mM NaCl, 10 mM dithiothreitol, and 10 μg/ml bovine serum albumin. Reaction components except DNA were pre-equilibrated 15 min at 37°C. Reactions were initiated by addition of DNA, were allowed to proceed 15 min at 37°C, and were terminated by addition of 150 µl ice-cold 10% (w/v) TCA. After 30 min on ice, the resulting TCA precipitates were collected on glass-fiber filters (UniFilter GF/C; Perkin-Elmer) using a 96-well harvester (Packard). filters were washed once with water, and radioactivity was quantified using a TopCount scintillation counter (Packard).
For experiments in Fig. 1b assessing transcription by φ6 RNA-dependent RNAP, reaction mixtures contained (20 µl): 0-400 µM PUM, 0.5 U φ6 RNAP (Thermo Fisher), 2 µg poly(A) ssRNA (GE Healthcare), 1 µM poly(U-15) ssRNA primer (Sigma-Aldrich), 400 µM ATP, 400 µM GTP, 400 µM CTP, and 1.56 µM [α 32 P]UTP (0.02 Bq/fmol; Perkin-Elmer) in 50 mM Tris-acetate (pH 8.7), 50 mM ammonium acetate, and 1.5 mM MnCl 2 . Reaction components other than RNA template, RNA primer, and NTPs were pre-incubated 10 min at 30°C. Reactions were initiated by addition of RNA template, RNA primer, and NTPs, reactions were allowed to proceed 1 h min at 30°C, and reactions were terminated by spotting on DE81 filter discs (Whatman; pre-wetted with water) and incubating 1 min at 22°C. Filters were washed with 3x3 ml 0.5 M sodium phosphate dibasic, 2x3 ml water, and 3 ml ethanol using a filter manifold (Hoefer); filters were placed in scintillation vials containing 10 ml Scintiverse BD Cocktail (Thermo Fisher); and radioactivity was quantified by scintillation counting (LS6500; Beckman-Coulter).
For experiments in Extended Data Table 1 For experiments in Extended Data Figs. 4c and 7c, fluorescence-detected transcription assays were performed essentially as described 5 .
Half-maximal inhibitory concentrations (IC50s) were calculated by non-linear regression in SigmaPlot (Systat Software).
Antibacterial activity in vitro
Antibacterial activities in vitro (Fig. 1c , rows 1-20; Extended Data Fig. 7d ) were determined using broth-microdilution growth-curve assays 41 (PUM degrades in phosphate-containing media with a half-life of ~12 h. Broth-microdilution endpoint assays 42 , which have a run time of 16-24 h 42 , which corresponds to 1.3 to 2 PUM half-lives, under-estimate absolute antibacterial activities of PUM. Broth-microdilution growth-curve assays 41 , which have shorter run times between assay start and assay signal, more accurately estimate absolute antibacterial activities of PUM.) Colonies of the indicated bacterial strains (5 to 10 per strain) were suspended in 3 ml phosphate-buffered saline 37 , suspensions were diluted to 1x10 5 cfu/ml with growth medium [Todd Hewitt broth (BD Biosciences) for Streptococcus pyogenes and Streptococcus pneumoniae, aged Mueller Hinton II cation-adjusted broth (BD Biosciences; autoclaved and allowed to stand 2-12 months at room temperature before use) for Staphylococcus aureus and Enterococcus faecium, fresh Mueller Hinton II cation-adjusted broth (autoclaved and used immediately) for Moraxella catarrhalis, or fresh Mueller Hinton II cation-adjusted broth (BD Biosciences; autoclaved and used immediately) containing 0.4% Haemophilus Test Medium 43 and 0.5% yeast extract for Haemophilus influenzae], 50 μl aliquots were dispensed into wells of a 96-well microplate containing 50 μl of the same medium or 50 μl of a 2-fold dilution series of PUM in the same medium (final concentrations = 0 and 0.25-256 μM), plates were incubated at 37°C with shaking, and optical densities at 600 nm were recorded at least hourly using a Synergy 2 (BioTek) or GENios Pro (Tecan) microplate reader. For each dilution series, growth curves were plotted, areas under growth curves were calculated, and IC50 was extracted as the lowest tested concentration of PUM that reduced area under the growth curve to 50% that in the absence of PUM (using only time points for rise phase of the growth curve in the absence of PUM).
Identical results were obtained in assays in the absence and presence of 30% human serum (Sigma-Aldrich; Fig. 1c , rows 1-4), indicating that PUM does not bind tightly to human serum proteins (unbound fraction ~100%).
Cytotoxicities for human macrovascular endothelial cells and human monocytes in culture ( Fig.  1c , rows 21-22) were determined as described 44 .
Antibacterial activity in vivo
Antibacterial activity in vivo was assessed in a mouse S. pyogenes peritonitis model ( Fig. 1d ; Extended Data Table 2 ). Female ICR mice (weight = 23-25 g; Harlan Laboratories Italy) were adapted to standardized environmental conditions (temperature = 23 ± 2°C; humidity = 55% ± 10%) for one week prior to infection. Infection was induced by intraperitoneal injection of 0.5 ml saline solution (supplemented with 1% peptone) containing 4 x 10 3 cfu S. pyogenes C203 (an inoculum resulting in ≥95% mortality in untreated controls within 48 to 72 h after infection). Infected mice (eight mice per group; number determined by power calculations; assigned randomly to groups; unblinded) were treated with either: (i) 0.2 ml 5% dextrose or 0.2 ml of a 2.5-fold dilution series of PUM in 5% dextrose, administered intravenously 10 min after infection and again 6 h after infection (total PUM dose = 0 or 3.2-50 mg/kg), (ii) 0.25 ml 5% dextrose or 0.25 ml of a 2.5-fold dilution series of PUM in 5% dextrose, administered intravenously 10 min after infection (total PUM dose = 0 or 1.024-40 mg/kg), or (iii) or 0.25 ml 5% dextrose or 0.25 ml of a 2.5-fold dilution series of PUM in 5% dextrose, administered subcutaneously 10 min after infection (total PUM dose = 0 or 1.024-40 mg/kg). Survival was monitored for 7 days after infection. Experiments were performed in compliance with vertebrate animal ethical regulations and with Institutional Animal Care and Use Committee (IACUC) approval.
ED50s (doses yielding 50% survival at 7 days) and 95% confidence limits were calculated using the trimmed Spearman-Karber method as implemented in the US EPA LC50 Model System (http://sdi.odu.edu/model/lc50.php) 45 .
Checkerboard interaction assays
Antibacterial activities of combinations of PUM and Rif were assessed in checkerboard interaction assays [46] [47] (Fig. 1e ). Broth-macrodilution (assays procedures essentially as described 42 ) were performed in checkerboard format, using S. pyogenes strain L49 or S. pneumoniae strain L44, and using Todd Hewitt broth (BD Biosciences) containing pairwise combinations of: (i) PUM at 1x, 0.5x, 0.25x, 0.125x, 0.063x, 0.031x, 0.016x, and 0.0078x MIC PUM and (ii) Rif at 0.8x, 0.4x, 0.2x, 0.1x, 0.05x, 0.025x, and 0.0125x MIC Rif . Fractional inhibitory concentrations (FICs), FIC indices (FICIs), and minimum and maximum FICIs (FICI min and FICI max ) were calculated as described 47 . FICI min ≤ 0.5 was deemed indicative of super-additivity (synergism), FICI min > 0.5 and FICI max ≤ 4.0 was deemed indicative of additivity, and FICI max > 4.0 was deemed indicative of sub-additivity (antagonism) [46] [47] .
Spontaneous resistance rate assays
Spontaneous resistance rates were determined in Luria-Delbrück fluctuation assays 48 (Fig. 2a ). S. pyogenes strain ATCC 12344 (~1 x 10 9 cfu/plate) was plated on Todd Hewitt agar [Todd Hewitt broth (BD Biosciences) supplemented with 1.5% Bacto agar (BD Biosciences)] containing 64 μg/ml or 128 μg/ml PUM (8x or 16x MIC under these conditions) or 1 μg/ml or 2 μg/ml Rif (8x or 16x MIC under these conditions), and numbers of colonies were counted after 24 h at 37°C (at least six independent determinations each). Resistance rates and 95% confidence intervals were calculated using the Ma-Sandri-Sarkar Maximum Likelihood Estimator [49] [50] as implemented on the Fluctuation Analysis Calculator (http://www.keshavsingh.org/protocols/FALCOR.html) 51 .
Spontaneous PUM-resistant mutants, S. pyogenes.
To isolate spontaneous PUM-resistant mutants of S. pyogenes (Fig. 2b) , a single colony of S. pyogenes ATCC 12344 was inoculated into 5 ml Todd Hewitt broth (BD Biosciences) and incubated 3 h at 37°C with shaking in a 7% CO 2 /6% O 2 /4% H 2 /83% N 2 atmosphere (atmosphere controlled using Anoxomat AN2CTS; Advanced Instruments), the culture was centrifuged, and the cell pellet (~1 x 10 9 cells) was re-suspended in 50 μl Todd Hewitt broth and plated on Todd Hewitt agar (BD Biosciences) containing 16-256 μg/ml PUM (2-32x MIC under these conditions), and plates were incubated 120 h at 37°C in a 7% CO 2 /6% O 2 /4% H 2 /83% N 2 atmosphere. PUM-resistant mutants were identified by the ability to form colonies on these media, were confirmed to be PUM-resistant by re-streaking on the same media, and were confirmed to be S. pyogenes, (as opposed to contaminants) using Taxo A differentiation discs (BD Biosciences) and Pyrase strips (Fluka).
Genomic DNA was isolated using the Wizard Genomic DNA Purification Kit [Promega; procedures as specified by the manufacturer, but with cells lysed using 1 mg/ml lysozyme (Sigma-Aldrich)] and was quantified by measurement of UV-absorbance (procedures as described 37 ). The rpoC gene and the rpoB gene were PCR-amplified in reactions containing 0.2 μg genomic DNA, 0.4 μM forward and reverse oligodeoxyribonucleotide primers (5'-GGGCAAATGATAACTTAGTTGCGATTTGCTG-3' and 5'-CCTTTCTGCCTTTGATGACTTTACCAGTTC-3' for rpoB; 5'-GCTCAAGAAACTCAAGAAGTTTCTGAAACAACTGAC-3' and 5'-GTCAATGCTTTTTACTGCCAACAAACTCAGAC-3' for rpoC), 5 U Taq DNA polymerase (Genscript), and 800 μM dNTP mix (200 μM each dNTP; Agilent/Stratagene) (initial denaturation step of 3 min at 94°C; 30 cycles of 30 s at 94°C, 45 s at 53°C, and 4 min at 68°C; final extension step of 10 min at 68°C). PCR products containing the rpoC gene (3.6 kB) or the rpoB gene (3.6 kB) were isolated by electrophoresis on 0.8% agarose gels (procedures as described 37 ), extracted from gel slices using a Gel/PCR DNA Fragments Extraction Kit (IBI Scientific; procedures as specified by the manufacturer), and sequenced (GENEWIZ; Sanger sequencing; seven sequencing primers per gene).
Spontaneous PUM-resistant mutants, E. coli
To isolate spontaneous PUM-resistant mutants of E. coli (Extended Data Fig. 4a ), E. coli uptake-proficient, efflux-deficient strain D21f2tolC 52 was cultured to saturation in 10 ml LB broth 37 at 37°C, cultures were centrifuged, cell pellets (~1 x 10 10 cells) were re-suspended in 50 μl LB broth and plated on LB agar 37 containing 800 μg/ml PUM (~1x MIC under these conditions), and plates were incubated 96-120 h at 37°C. PUM-resistant mutants were identified by the ability to form colonies on this medium. Genomic DNA was isolated, and rpoB and rpoC genes were PCR-amplified and sequenced as described 18 .
Resistance and cross-resistance levels
Resistance levels of S. pyogenes and E. coli spontaneous PUM-resistant mutants ( Fig. 2b  Extended Data Fig. 4b ) were quantified in broth-microdilution assays. A single colony of a mutant strain or the isogenic wild-type parent strain was inoculated into 5 ml Todd Hewitt broth (BD Biosciences; for S. pyogenes) or LB broth 37 (for E. coli) and incubated at 37°C with shaking in a 7% CO 2 /6% O 2 /4% H 2 /83% N 2 atmosphere (atmosphere controlled using Anoxomat AN2CTS; Advanced Instruments); for S. pyogenes) or in air (for E. coli) until OD 600 = 0.4-0.8. Diluted aliquots (~2 x 10 5 cells in 50 μl same medium) were dispensed into wells of a 96-well microplate containing 50 μl of the same medium or 50 μl of a 2-fold dilution series of PUM in the same medium (final PUM concentration = 0 or 0.098-800 μg/ml), and were incubated 16 h at 37°C with shaking in a 7% CO 2 /6% O 2 /4% H 2 /83% N 2 atmosphere (for S. pyogenes) or in air (for E. coli). MIC was defined as the lowest tested concentration of PUM that inhibited bacterial growth by ≥90%. MIC/MIC wild-type was defined as the ratio of MIC for mutant to MIC for isogenic wild-type parent (S. pyogenes MIC wild-type = 6.25 μg/ml under these conditions; E. coli MIC wild-type = 400 μg/ml under these conditions).
Cross-resistance levels of S. pyogenes and E. coli spontaneous PUM-resistant mutants ( Fig. 2e ; Extended Data Fig. 4f ) were determined as in the preceding paragraph, but using culture aliquots (~1x10 5 cells) in 97 μl growth medium supplemented with 3 μl methanol or 3 μl of a 2-fold dilution series of Rif (Sigma-Aldrich; S. pyogenes MIC wild-type = 0.098 μg/ml; E. coli MIC wild-type = 0.20 μg/ml), lipiarmycin A3 (Lpm; BioAustralis; S. pyogenes MIC wild-type = 6.25 μg/ml; E. coli MIC wild-type = 1.56 μg/ml), myxopyronin B (Myx; prepared as described 53 ; S. pyogenes MIC wild-type = 6.25 μg/ml; E. coli MIC wild-type = 0.20 μg/ml), streptolydigin (Stl; Sourcon-Padena; S. pyogenes MIC wild-type = 3.13 μg/ml; E. coli MIC wild-type = 3.13 μg/ml), CBR703 (CBR; Maybridge; E. coli MIC wild-type = 6.25 μg/ml), or salinamide A (Sal; W. Fenical, Scripps Institution of Oceanography; E. coli MIC wild-type = 0.049 μg/ml) in methanol (final concentrations = 0 and 0.006-50 μg/ml), or using culture aliquots (~2x10 5 ) cells in 50 μl growth medium supplemented with 50 μl growth medium or 50 μl of a 2-fold dilution series of GE23077 (GE; prepared as described 54 ; E. coli MIC wild-type = 500 μg/ml) in growth medium (final concentrations = 0 and 125-8000 μg/ml).
Cross-resistance levels of S. pyogenes Rif-resistant mutants to PUM (Fig. 1e ) were determined were determined as described for cross-resistance levels of S. pyogenes spontaneous PUM-resistant mutants, but analyzing a collection of 13 S. pyogenes spontaneous Rif-resistant mutants [isolated and sequenced using the same procedures used for isolation and sequencing of S. pyogenes PUM-resistant mutants (Methods, Spontaneous PUM-resistant mutants, S. pyogenes), but using Todd Hewitt agar containing 1-16x MIC Rif (0.1-2 μg/ml under these conditions)] and the isogenic wild-type parent, and analyzing a 2-fold dilution series of PUM (final concentration = 0 or 1.56-100 μg/ml).
Cross-resistance levels of E. coli Rif-, Lpm-, Myx-, and Sal-resistant mutants to PUM (Extended Data Fig. 4g -i,l) were determined as described for resistance levels of E. coli spontaneous PUM-resistant mutants, but analyzing a collection of E. coli D21f2tolC derivatives 18 comprising four chromosomal Rif-resistant mutants, five chromosomal Lpm-resistant mutants, five chromosomal Myx-resistant mutants, five chromosomal Sal-resistant mutants, and the isogenic wild-type parent, and analyzing a 2-fold dilution series of PUM (final concentration = 0 or 25-1600 μg/ml).
Cross-resistance levels of E. coli Stl-, CBR-, and GE-resistant mutants to PUM (Extended Data Fig. 4j -k,n) were determined analogously, analyzing a collection of E. coli D21f2tolC pRL706 and E. coli D21f2tolC pRL663 derivatives 5,14,16 comprising five plasmid-based Stl-resistant mutants, five plasmidbased CBR-resistant mutants, six plasmid-based GE-resistant mutants, and plasmid-based wild-type isogenic parents. Single colonies were inoculated into 5 ml LB broth containing 200 μg/ml ampicillin (Sigma-Aldrich), incubated at 37°C with shaking until OD 600 = 0.4-0.8, supplemented with IPTG (Gold Bio) to a final concentration of 1 mM, and further incubated 1 h at 37°C with shaking. Diluted aliquots (~2 x 10 5 cells in 50 μl LB broth containing 200 μg/ml ampicillin and 1 mM IPTG) were dispensed into wells of a 96-well microplate containing 50 μl of the same medium or 50 μl of a 2-fold dilution series of PUM in the same medium (final concentration = 0 or 25-4000 μg/ml), and were incubated 16 h at 37°C with shaking.
Amino-acid substitutions that confer PUM-resistance in the context of S. pyogenes RNAP were re-constructed and re-analyzed in the context of E. coli RNAP using an E. coli plasmid-based resistance assay (Extended Data Fig. 4b ). Site-directed mutagenesis (QuikChange Site-Directed Mutagenesis Kit; Agilent) was used to construct plasmid pRL706 28 and pRL663 55 derivatives encoding E. coli RNAP β-subunit and β'-subunit derivatives having amino-acid substitutions that confer PUM-resistance in S. pyogenes (sequences from Fig. 2b ). The resulting plasmids were introduced by transformation into E. coli strain D21f2tolC 52 , and resistance levels of transformants were determined using the procedures of the preceding paragraph.
Formation of RNAP-promoter open complex
Experiments (Extended Data Fig. 4a ) were performed essentially as described 12 . Reaction mixtures contained (20 μl): test compound (0 or 500 μM PUM, 2 μM Rif, or 100 μM Lpm), 40 nM E. coli RNAP σ 70 holoenzyme, 10 nM Cy5-labelled DNA fragment carrying positions -40 to +15 of lacUV5 promoter (lacUV5-[-40;+15]-Cy5 12 ), and 100 μg/ml heparin, in 50 mM Tris-HCl (pH 8.0), 100 mM KCl, 10 mM MgCl 2 , 1 mM dithiothreitol, 10 μg/ml bovine serum albumin, and 5% glycerol. Reaction components other than DNA and heparin were incubated 10 min at 37°C; DNA was added and reactions were incubated 15 min at 37°C; and heparin was added and reactions were incubated 2 min at 37°C. Products were applied to 5% TBE-polyacrylamide slab gels (Bio-Rad), electrophoresed in TBE 37 , and analyzed by fluorescence scanning (Typhoon 9400).
Nucleotide addition in transcription initiation.
Experiments were performed essentially as described 5 , using reaction mixtures that contained no inhibitor, 500 μM PUM, 2 μM Rif, or 100 μM Lpm, and using 5 μM [α 32 P]UTP (3 Bq/fmol; PerkinElmer) (Extended Data Fig. 4b ).
Nucleotide addition in transcription elongation
Experiments were performed essentially as described 5 , using reaction mixtures that contained no inhibitor, 500 μM PUM, 2 μM Rif, or 100 μM Lpm (Extended Data Fig. 4c ).
Nucleotide addition at elevated NTP concentrations
Experiments (Fig. 3a ) were performed essentially as described above for assays of 
Nucleotide addition on standard and "U-less cassette" templates
Experiments (Fig. 3b ) were performed essentially as described in the preceding section (Methods, Nucleotide addition at elevated NTP concentrations), using reaction mixtures (50 μl) that contained 0-20 µM PUM, 0.4 U E. coli RNAP σ 70 holoenzyme (Epicentre), 2 µM [α 32 P]CTP (0.2 Bq/fmol; PerkinElmer), 100 µM ATP, 100 µM GTP, and 5 µM UTP, in 40 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 5 mM dithiothreitol, 15 mM KCl, 0.01 % Triton X-100, and 100 μg/ml bovine serum albumin, and either (i) 50 nM DNA fragment carrying positions -112 to +8 of E. coli recA promoter 36 followed by 5'-CAGGGACAAGTTAGTTCGTTCAGCGACACGCGGCAACAAG-3' (directs incorporation of U, G, A, and C) or (ii) 50 nM DNA fragment carrying positions -112 to +8 of E. coli recA promoter followed by 5'-CAGGGACAAGGAGACCAACGCAGCGACACGCGGCAACAAG-3' ("U-less cassette"; directs incorporation of G, A, and C). ). The reaction time was 60 min at 37°C. Relative nucleotide incorporation was defined as the ratio of nucleotide incorporation in the presence of PUM to nucleotide incorporation in the absence of PUM.
Template-sequence specificity of inhibition by PUM: single-nucleotide-addition reactions
Template-sequence specificity of inhibition by PUM was assessed in single-nucleotide-addition experiments (Fig. 3c ) using E. coli RNAP transcription elongation complexes assembled on the following nucleic-acid scaffolds (black, DNA; red, RNA; asterisk, 32 100 mM KCl, 10 mM MgCl 2 , 1 mM dithiothreitol, 10 μg/ml BSA, and 5% glycerol. Reaction components except PUM and NTP were pre-incubated 10 min at 37°C, PUM was added and reaction mixtures were incubated 5 min at 37°C, and NTP was added and reaction mixtures were incubated 5 min at 37°C. Reactions were terminated by addition of 5 μl 80% formamide, 10 mM EDTA, 0.04% bromophenol blue, 0.04% xylene cyanol, and 0.08% amaranth red, and heating 2 min at 95˚C. Samples were applied to denaturing 15% polyacrylamide (19:1 acrylamide:bisacrylamide, 7 M urea) 37 slab gels, electrophoresed in TBE 37 , and analyzed by storage-phosphor scanning (Typhoon 9400; GE Healthcare).
Template-sequence specificity of inhibition by PUM: multiple-nucleotide-addition reactions
Template-sequence specificity of inhibition by PUM was assessed in multiple-nucleotide-addition experiments (Fig. 3d) , performed by adding PUM to transcription elongation complexes halted at position +29 of a 100 bp transcription unit by omission of CTP, re-starting transcription elongation complexes and allowing transcription of positions +30 to +100 of the transcription unit by addition of CTP, and identifying positions at which PUM inhibits transcription.
Halted transcription elongation complexes were prepared as described 56 . Reaction mixtures (20 μl) contained: 40 nM E. coli RNAP σ 70 holoenzyme, 10 nM DNA fragment N25-100-tR2 56 were terminated by addition of 12.5 μl 80% formamide, 10 mM EDTA, 0.04% bromophenol blue, 0.04% xylene cyanol, and 0.08% amaranth red, and heating 4 min at 95˚C. Samples were applied to 10% polyacrylamide (19:1 acrylamide:bisacrylamide; 7 M urea) 37 slab gels, electrophoresed in TBE 37 , and analyzed by storage-phosphor scanning (Typhoon 9400).
Structure determination: RPo-GpA-PUM
Crystals of T. thermophilus RPo-GpA were prepared as described 26 . Crystallization drops contained 1 μl 18 μM RPo (prepared from T. thermophilus RNAP σ A holoenzyme and synthetic nucleicacid scaffold as described 26 ) and 1 mM GpA (RiboMed) in 20 mM Tris-HCl, pH 7.7, 100 mM NaCl, and 1% glycerol, and 1 μl reservoir buffer (RB; 100 mM Tris-HCl, pH 8.4, 200 mM KCl, 50 mM MgCl 2 , and 10% PEG4000), and were equilibrated against 400 μl RB in a vapor-diffusion hanging-drop tray (Hampton Research). Rod-like crystals appeared in 1 day, and grew to a final size of 0.1 mm x 0.1 mm x 0.3 mm in 5 days.
PUM was soaked into RPo-GpA crystals by adding 0.2 μl 100 mM PUM in RB to the crystallization drop and incubating 30 min at 22°C. RPo-GpA-PUM crystals were transferred to reservoir solutions containing 2 mM PUM in 17.5% (v/v) (2R,3R)-(-)-2,3-butanediol (Sigma-Aldrich) and were flash-cooled with liquid nitrogen.
Diffraction data for RPo-GpA-PUM were collected from cryo-cooled crystals at Cornell High Energy Synchrotron Source (CHESS) beamline F1. Data were integrated and scaled using HKL2000 57 . Structure factors were converted using the French-Wilson algorithm in Phenix 58 and were subjected to anisotropy correction using the UCLA MBI Diffraction Anisotropy server (http://services.mbi.ucla.edu/anisoscale/) 59 .
The structure of RPo-GpA-PUM was solved by molecular replacement in Molrep 60 , using one RNAP molecule from the structure of T. thermophilus RPo (PDB 4G7H 26 ) as the search model.
Early-stage refinement included rigid-body refinement of each RNAP molecule, followed by rigid-body refinement of each subunit of each RNAP molecule. Cycles of iterative model building with Coot 61 and refinement with Phenix 62 were performed. Atomic models of the DNA nontemplate strand, the DNA template strand, and GpA were built into mFo-DFc omit maps, and further refinement with Phenix was performed. The atomic model of PUM was built into the mFo-DFc omit map and was refined with Phenix. The final crystallographic model of RPo-GpA-PUM at 3.30 Å resolution, refined to Rwork and Rfree of 0.232 and 0.280, has been deposited in the PDB with accession code 5X21 ( Fig. 4a ; Extended Data Table 3 ).
Structure determination: RPo-GpA-CMPcPP
Crystals of T. thermophilus RPo-GpA-CMPcPP were prepared by co-crystallization. Crystallization drops contained 1 μl 18 μM RPo (prepared from T. thermophilus RNAP σ A holoenzyme and synthetic nucleic-acid scaffold as described 26 ), 1 mM GpA (RiboMed), and 10 mM CMPcPP (Jena Bioscience) in 20 mM Tris-HCl, pH 7.7, 100 mM NaCl, and 1% glycerol, and 1 μl RB, and were equilibrated against 400 μl RB in a vapor-diffusion hanging-drop tray (Hampton Research). Rod-like crystals appeared in 1 day, and grew to a final size of 0.1 mm x 0.1 mm x 0.3 mm in 5 days. RPo-GpA-CMPcPP crystals were transferred to reservoir solutions containing 2 mM CMPcPP in 17.5% (v/v) (2R,3R)-(-)-2,3-butanediol (Sigma-Aldrich), and were flash-cooled with liquid nitrogen.
Diffraction data for RPo-GpA-CMPcPP were collected from cryo-cooled crystals at CHESS beamline F1. Data were integrated and scaled, structure factors were converted and subjected to anisotropy correction, and the structure was solved and refined using procedures analogous to those in the preceding section. The final crystallographic model of RPo-GpA-CMPcPP at 3.35 Å resolution, refined to Rwork and Rfree of 0.208 and 0.250, has been deposited in the PDB with accession code 5X22 ( Fig.  4b ; Extended Data Table 3 ).
Semi-synthesis of PUM derivatives
Semi-syntheses of PUM derivatives from PUM corroborate the inferred structure of PUM, provide routes for preparation of novel PUM derivatives, and provide initial structure-activity relationships (Extended Data Fig. 7a,c-d ). Reactions were conducted starting from 1 mg PUM, and products were identified by LC-MS (Agilent 1100 with flow split in 1:1 ratio between UV detector and ion-trap ESI-MS interface of Bruker Esquire 3000 Plus; Waters Atlantis 3 μm, 50 x 4.6 mm, column; phase A = 0.05% trifluoroacetic acid in water; phase B = acetonitrile; gradient = 5-95% B in 6 min; flow rate = 1 ml/min; run temperature = 40°C; PUM retention time = 1.4 min).
Reaction of PUM with TiCl 3 in 1 M sodium acetate (pH 7.0) for 2 h at room temperature resulted in reduction of the N-hydroxy moiety, yielding desoxy-PUM (1; m/z = 471 [M+H] + ). Reaction of PUM with PdCl 2 63 in 1:1 acetonitrile:water for 2 h at room temperature resulted in selective dehydration of the PUM glutamine sidechain amide -NH2, yielding nitrile analog 2 (m/z = 469 [M+H] + ). Reaction of PUM with 0.1% TFA in water for 3 days at room temperature resulted in hydrolysis of the glutamine sidechain amide, yielding carboxy analog 3 (m/z = 488 [M+H] + ). Reaction of 3 with benzylamine in DMF containing benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) for 30 min at room temperature yielded benzylamide analog 4 (m/z = 577 [M+H] + ). Reaction of PUM with 2,3butanedione 64 in 10 mM ammonium acetate (pH 8.0) for 30 min at room temperature resulted in diolic intermediate 5 (m/z = 573 [M+H] + ), which subsequently was trapped by treatment with phenylboronic acid for 2 h at room temperature, yielding phenyl-dioxaborolan analog 6 (m/z = 659 [M+H] + ).
Total synthesis of desoxy-PUM
Total synthesis of desoxy-PUM provides a reference compound that corroborates the inferred stereochemistry of PUM [by comparison of desoxy-PUM prepared by total synthesis (1 in Extended Data Fig. 7b ) to desoxy-PUM prepared by semi-synthesis from PUM (1 in Extended Data Fig. 7a ] and provides an additional route to novel PUM derivatives. Desoxy-PUM was obtained in eight steps by 
